Rates of one type of breast cancer — invasive lobular carcinoma — have been rising in the United States more than three times faster than those of all other breast cancers combined over the past ...
Invasive lobular carcinoma accounts for about 10% of breast cancer diagnoses. Its incidence is increasing at the rate of 2.8% annually -- more than triple that of other breast cancers combined. This ...
Lobular breast cancer rates increased 2.8 percent per year over the past decade, compared with a 0.8 percent annual increase for all other breast cancers. Lobular breast cancer grows in a linear ...
Lobular breast cancer patients gathered at Fred Hutch Cancer Center last week for a two-hour program featuring patient stories, epidemiological findings and new developments in screening and clinical ...
Stage 0 cancer, known medically as carcinoma in situ (CIS), is considered the earliest detectable phase of cancer formation. At this stage, abnormal cells are present only in the layer of tissue where ...
SHREVEPORT, La. -- As Breast Cancer Awareness Month comes to a close, there’s encouraging news that more Americans are surviving cancer overall. But experts say there’s still much to learn—especially ...
Longer-term trial results show Voranigo may help control grade 2 IDH-mutated glioma after surgery for those who can delay chemotherapy and radiation. Longer-term results show that Voranigo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results